[Congressional Record Volume 167, Number 213 (Thursday, December 9, 2021)]
[Extensions of Remarks]
[Pages E1351-E1352]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                IN RECOGNITION OF HOSSAM MAKSOUD, PHARMD

                                 ______
                                 

                        HON. CAROLYN B. MALONEY

                              of new york

                    in the house of representatives

                       Thursday, December 9, 2021

  Mrs. CAROLYN B. MALONEY of New York. Madam Speaker, I rise to pay 
tribute to Dr. Hossam Maksoud for his outstanding career and dedication 
to creating accessible health services. For over twenty-five years, Dr. 
Maksoud has been at the forefront of providing affordable medication 
and healthcare.
  When Dr. Maksoud received his pharmaceutical degree in 1990 from St. 
John's University's School of Pharmacy, he already had an established 
family business and chain of pharmacies in Egypt. Dr. Maksoud used this 
entrepreneurial experience in the United States to establish Maksoud 
Pharm, Inc in 1993.
  Maksoud Pharm grew into a chain of independent retail pharmacies in 
the New York tristate area. With the revenues generated from Maksoud 
Pharm, Dr. Maksoud was able to launch his long-term care pharmacy 
company, Community Care Rx.
  Dr. Maksoud currently serves as Chief Executive Officer of Community 
Care Rx. As a

[[Page E1352]]

long-term care pharmacy, the company serves Adult & Pediatric 
Residential Programs, Assisted Living Facilities, Hospital Discharge 
Programs, HIV Programs, Hospital and Nursing Home Discharges and 
Skilled Nursing Facilities. Community Care Rx has a specific focus on 
nonprofit organizations that serve individuals unable to care for 
themselves.
  Dr. Maksoud's goal is to address pharmaceutical drug shortages, 
working with lists provided by the Food and Drug Administration (FDA). 
Over the years, Dr. Maksoud created additional healthcare companies to 
confront shortage concerns, such as Community Care Specialty Pharmacy, 
which is URAC and ACHC accredited, to address the difficulty in 
obtaining specialty disease state medications for patients. Dr. Maksoud 
also created Community Care Consulting, which reviews patients' 
medication charts in order to reduce patient and facility financial 
burdens.
  In 2017, Dr. Maksoud once again launched an initiative to address the 
drug shortage problem. With four partners, he created Dawah 
Pharmaceuticals, Inc., a drug manufacturing company. Dawah 
Pharmaceuticals aims to provide affordable medication to the market by 
producing generic versions of otherwise widely inaccessible medication. 
One of these generics is currently under review by the FDA and has a 
projected release in the second quarter of 2022. In partnership with 
Oakrum Pharma, Dawah Pharmaceuticals will market the medication through 
wholesale distribution across the United States, to the benefit of 
institutions such as hospitals and clinics.
  Dr. Maksoud is a board member of the Egyptian African Business 
Association (EABA) and is an active participant in many long-term care 
and nonprofit associations in the tristate area, such as IAC, ESAAL, 
NYAEMP, NYSACRA, HCANJ, and NJACP. Additionally, Dr. Maksoud, along 
with his family, established The Maksoud Foundation, which assists the 
elderly in obtaining medication they cannot afford.
  As a dual citizen of Egypt and the United States with extensive 
experience living and working in multiple countries, Dr. Maksoud brings 
a unique perspective to his work. His global experience has 
demonstrated to him the importance and the value of diversity and 
community philanthropy.
  Madam Speaker, I ask my colleagues to join me in recognizing Dr. 
Hossam Maksoud for his community service, his generosity, and 
especially his commitment to providing affordable medication and 
increasing access to quality healthcare.

                          ____________________